Callable Multi Barrier Reverse Convertible

Symbol: UNOLTQ
ISIN: CH1194699547
Issuer:
Leonteq Securities
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 62.54
Diff. absolute / % -11.89 -19.01%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Callable Multi Barrier Reverse Convertible
ISIN CH1194699547
Valor 119469954
Symbol UNOLTQ
Quotation in percent Yes
Coupon p.a. 9.00%
Coupon Premium 8.23%
Coupon Yield 0.77%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached Yes (Pfizer Inc. - 10/11/2023)
COSI Product No
Exercise type American
Currency Swiss Franc
First Trading Date 08/07/2022
Date of maturity 08/07/2024
Last trading day 01/07/2024
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Dirty
Issuer Leonteq Securities

Key data

Sideways yield p.a. -

market maker quality Date: 30/04/2024

Average Spread -
Last Best Bid Price 48.34 %
Last Best Ask Price - %
Last Best Bid Volume 250,000
Last Best Ask Volume 0
Average Buy Volume 0
Average Sell Volume 0
Average Buy Value 0 CHF
Average Sell Value 0 CHF
Spreads Availability Ratio 0.00%
Quote Availability 100.00%

Underlyings

Name Pfizer Inc. Sanofi S.A. Johnson & Johnson Bayer AG
ISIN US7170811035 FR0000120578 US4781601046 DE000BAY0017
Price 25.965 EUR 92.415 EUR 140.38 EUR 28.33 EUR
Date 03/05/24 08:39 03/05/24 08:40 03/05/24 08:39 03/05/24 08:40
Cap 52.31 USD 97.52 EUR 179.52 USD 57.35 EUR
Distance to Cap -24.755 -4.56 -29.27 -30
Distance to Cap in % -89.84% -4.91% -19.48% -109.69%
Is Cap Level reached No No No No
Barrier 29.29 USD 54.61 EUR 100.53 USD 32.12 EUR
Distance to Barrier 0.160001 37.29 49.41 -3.99
Distance to Barrier in % 0.54% 40.58% 32.95% -14.18%
Is Barrier reached Yes No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.